Sat.Dec 25, 2021 - Fri.Dec 31, 2021

article thumbnail

Body positive for obesity?

World of DTC Marketing

When obesity has become a national health crisis caused by overeating and lack of exercise, a body positivity website has created free “Don’t Weigh Me” cards for patients who find stepping on the scale at the doctor’s office stressful. The group supports a “Health at Every Size” philosophy, based around the assumption that “the current practice of linking weight to health using BMI (body mass Index) standards is biased and unhelpful.” An analysis p

Doctor 43
article thumbnail

J&J goes after another FDA approval for a cancer bispecific

pharmaphorum

Johnson & Johnson’s much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second candidate. The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Google Reveals Top Food Searches of 2021

XTalks

Each year, Google reveals its annual list of top food searches, which are representative of the most popular food trends and recipes of the year. With half of this year’s list stemming from either celebrities or social media, it is clear that “going viral” has a major impact on what consumers are searching for. Here are the top ten food searches from Google in 2021 and what they reveal about the current status of the food and beverage industry.

Branding 104
article thumbnail

J. & J. Booster Protects Against Severe Omicron, Study Says

NY Times

Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Wegovy hype driving demand

World of DTC Marketing

The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment. The drug got a PR boost from Marc Andreessen, who called semaglutide a “silver bullet” and “miracle drug” for suppressing appetite. Unfortunately, the hype is going to exceed reality.

article thumbnail

Which pharmaceutical companies have the most drug patents in Spain?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

More Trending

article thumbnail

F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

NY Times

Regulators will also allow even younger children with immune deficiencies to get an extra shot.

article thumbnail

The cancer screening time bomb

World of DTC Marketing

Routine cancer screening is essential to detect cancers early when it is most curable. The consequence of millions of people missing cancer screenings because of the COVID pandemic is a delay in detecting cancer, which results in cancer progressing to a more advanced stage. According to a study published in JAMA Oncology, a publication of the American Medical Association, nearly 22 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic.

Research 187
article thumbnail

Association Between Immune Dysfunction and Breakthrough COVID-19 Infection After Vaccination

JAMA Internal Medicine

This cohort study compares COVID-19 incidence, risk, outcome severity, and treatment response between immunocompromised individuals and those without immune dysfunction conditions before and after SARS-CoV-2 vaccination.

Vaccine 75
article thumbnail

Penn Medicine awarded $14 million NIH grant to apply CAR T immunotherapies to match more patients in need of kidney transplants

Scienmag

PHILADELPHIA — Penn Medicine has been awarded a prestigious seven-year, $14 million grant from the National Institutes of Health (NIH) to promote organ transplantation for patients with end-stage renal disease who are currently on the waitlist for a kidney transplant. The team will launch a clinical trial harnessing synthetic chimeric antigen receptor (CAR) T cells […].

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Teva Pharmaceuticals Found Liable in Landmark Opioid Trial

NY Times

The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.

article thumbnail

Bayer Commits to 100 Percent Green Packaging by 2030

XTalks

Bayer has announced that all of its products will have 100 percent green packaging by 2030. The pharma giant says it will be investing €100 million towards achieving this target, which is part of the company’s sustainability program aimed at helping to protect the environment and combat climate change. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or re

article thumbnail

Teva will appeal opioid liability ruling in New York trial

pharmaphorum

The jury in a new York trial has found that Teva Pharmaceuticals played a role in fuelling the opioid crisis in the US, and should be held liable for damages, which will be decided later. The decision came after eight days of deliberation by the jurors, and almost six months of legal jousting between the drugmaker and its counsel and lawyers for the state of New York and two of its counties, Suffolk and Nassau.

Trials 52
article thumbnail

Is energy the key to Alzheimer’s disease?

Scienmag

A team of researchers at the University of Adelaide has found a link between the way that cells produce energy for brain function and the mutated genes found in Alzheimer’s disease. Credit: Pixabay. Photo by Pete Linforth. A team of researchers at the University of Adelaide has found a link between the way that cells […].

Gene 91
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Alzheimer's Drug Aduhelm Faces Crucial Medicare Decision

NY Times

Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.

Drugs 72
article thumbnail

Wearables in Clinical Trials: An Overview of Challenges

Cloudbyz

Wearable Tech-What’s It All About? Let’s start from the very beginning. What are people talking about when they say “wearables”, “wearable biosensors”, “wearable devices”, or “wearable technology” in clinical trials? In the most basic sense, all these terms refer to relatively mobile devices that you can wear on your person; designed to measure specific biological parameters in your body.

article thumbnail

The Chrismon Tree: The Weary World Rejoices

Pharma Packaging Solutions

Central’s Chrismon Tree began in 1977, when the women of the church made the first ornaments for our church tree. The number of Christian Christmas symbols on our tree has grown each year until we now have over one hundred. Our Chrismons are made in white, the liturgical color of Christmas, which refers to Christ’s purity and perfection, and gold, which refers to his majesty and glory.

52
article thumbnail

NAU scientists and students will utilize newly launched James Webb Space Telescope for solar system research

Scienmag

In one of the most exciting developments in astronomy in the 21st century, NASA is launching the James Webb Space Telescope (JWST) today—and Northern Arizona University astronomers, planetary astronomers and their students will be using the massive observatory to expand their research and advance our understanding of the solar system. Credit: Credit: Ball Aerospace In […].

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Una alternativa a las gafas: gotas para los ojos

NY Times

Un tratamiento que puede ayudar a la gente que necesita anteojos para ver de cerca, sin afectar su visión de largo alcance, salió al mercado en diciembre tras ser aprobado por la FDA en octubre.

Drugs 54
article thumbnail

Which pharmaceutical companies have the most drug patents in Slovenia?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Jesus 365

Pharma Packaging Solutions

2022! A fresh year, we hope. A new start, we pray. A chance to leave past pain and struggle in the past. But what are we moving toward? What are our dreams and aspirations, especially as a community of faith? Dare we ask what are God’s dreams for us as a community of faith? Our theme for 2022 is “Jesus 365.” We begin the year with a journey through Luke’s gospel, picking up the story this Sunday when Jesus is 12 years old and left behind in Jerusalem.

52
article thumbnail

Cylindrical vector beam multiplexer/demultiplexer using off-axis polarization control

Scienmag

Cylindrical vector beam (CVB) multiplexing has emerged as a powerful technique to boost signal channels. Coupling and separating CVBs are two pivotal elements in CVB multiplexing communication. Although off-axis control technologies, such as miniature Dammann vortex gratings, have been investigated to couple and separate light beams, it is usually limited to light beams with homogeneous […].

90
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation

BioTech 365

Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation Mission Viejo, California, United States, Dec.

article thumbnail

New tentative approval for Hospira Inc drug bortezomib

Drug Patent Watch

[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

For Yonder Breaks A New and Glorious Morn: The Weary World Rejoices

Pharma Packaging Solutions

We’ve likely all experienced beautiful sunrises in various places. Perhaps a never-ending ocean? An expansive high desert where one can see forever? A peaceful Smoky Mountain lookout? The broad Texas or Oklahoma plains? Your own backyard with multicolored sky? We’re reminded that day is not ending, but gloriously beginning. “O Holy Night” gives us imagery of the first Advent with the line, “for yonder breaks a new and glorious morn.

52
article thumbnail

Stopping dementia at the nose with combination of rifampicin and resveratrol

Scienmag

Dementia is thought to occur when proteins called amyloid-?, tau, and ?-synuclein accumulate in the brain and form oligomers. A research group from the Department of Translational Neuroscience, Osaka City University Graduate School of Medicine, had previously shown in a study using mice that the antibiotic rifampicin removes oligomers from the brain and improves cognitive […].

Protein 87
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing

BioTech 365

Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Mission Viejo, California, United States, Dec.

52
article thumbnail

New patent for Abbvie Inc drug MAVYRET

Drug Patent Watch

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

His Power and Glory Evermore Proclaim: The Weary World Rejoices

Pharma Packaging Solutions

But those who hope in the Lord will renew their strength. They will soar on wings like eagles; they will run and not grow weary, they will walk and not be faint. Isaiah 40:30 NIV This is my God story – a story of His peace, His love, and my hope. My hope was in the Lord during a long difficult journey of recovery and rehabilitation after a near-fatal car accident.

52
article thumbnail

Easy-to-take medicine better at suppressing HIV in children

Scienmag

UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Credit: Picturing Health, picturinghealth.org UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Peer-reviewed / Randomised controlled trial / People Easy-to-take medicine better at suppressing HIV in children A once-a-day […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.